On Tuesday, December 15, from 11 am to noon EST, The American Journal of Managed Care will host a tweetchat with Leah Binder, MA, MGA, president and CEO of The Leapfrog Group, about hospital quality ratings, patient safety, and healthcare outcomes.
PLAINSBORO, N.J.— In the most recent Hospital Safety Score report, The Leapfrog Group found a number of positive trends for certain hospital-acquired conditions and safety measures, but noted that areas for improvement remain.
On Tuesday, December 15, from 11 am to noon EST, The American Journal of Managed Care (AJMC) will host a tweetchat with Leah Binder, MA, MGA, president and CEO of The Leapfrog Group, about hospital quality ratings, patient safety, and healthcare outcomes.
Binder, who was the keynote speaker at AJMC’s ACO and Emerging Healthcare Delivery Coalition fall live meeting in October, will answer questions from participants and discuss topics that include the relevancy of individual hospital quality ratings, how the use of health technology has affected patient safety, and how consumers view quality ratings.
“Although progress has been made, we still need more transparency and accountability in our health care system,” said Binder. “I’m honored to partner with AJMC to have an open conversation with hospitals and purchasers on ways to improve quality, patient safety and transparency for consumers.”
AJMC and The Leapfrog Group encourage Twitter users to submit questions and participate in the chat on Tuesday, December 15, by using #AJMCchat. And don’t forget to follow @AJMC_Journal, @LeahBinder, and @LeapfrogGroup.
In March 2015, Binder wrote a commentary for AJMC’s sister publication, The American Journal of Accountable Care, highlighting the expanding surge of consumerism in healthcare.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
About The Leapfrog Group
Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey collects and transparently reports hospital performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. Hospital Safety Score, Leapfrog’s other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents, and infections.
Nicole Beagin (609) 716-7777 x 131
CONTACT:
Collaborative Care Model Offers Success in Reducing Suicide Risk, New Report Finds
April 10th 2025A report published today by the American Foundation for Suicide Prevention underscores the potential of the collaborative care model to lower suicide risk across diverse patient populations and health systems.
Read More
Sociodemographic Factors Impact Cytoreductive Surgery Decisions in Advanced Ovarian Cancer
April 9th 2025Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in nonmetropolitan areas, and were unmarried had higher odds of refusing cytoreductive surgery.
Read More
Meta-Analysis Finds SGLT2 Inhibitors Boost Hemoglobin, Hematocrit in CKD
April 8th 2025The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for patients with chronic kidney disease (CKD) not only for their established benefits but also for addressing anemia.
Read More
Worse CTD-PAH Prognosis Seen With Higher HFA-PEFF Score
April 8th 2025The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH) stratified by their Heart Failure Association–preserved ejection fraction (HFA-PEFF) algorithm score.
Read More